If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Data Management and Biostatics
Download FREE Excerpt
6 Info Graphics
27 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Real World Evidence (RWE) is a key driver of formulary and reimbursement decisions by both public and private payers and is an important focus area for global regulators. Consequently, the pharmaceutical industry has been boosting internal RWE capabilities and is increasingly outsourcing to vendors specializing in RWE generation.
Non-Safety Registries, which in this research encompass four RWE study methods, are utilized by many pharma companies. Best Practices, LLC conducted this study to gain insights into current and future utilization of these four study methods (Disease Registries, Product Registries (Not including Vaccine Registries), Pregnancy Registries, Vaccine Registries). In addition, the study presents benchmarks on the data collection methods used, the level of outsourcing used and valued vendor traits for these study types.
This study engaged 25 leaders within 19 global organizations with deep experience in managing Real World Evidence generation at top pharmaceutical companies.